Maryam Mahjoubin-Tehran

Dr. Maryam Mahjoubin-Tehran


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
EMElaheh Mianehsaz
Elaheh Mianehsaz
HMHamed Mirzaei
Hamed Mirzaei
MMMaryam Mahjoubin-Tehran
Maryam Mahjoubin-Tehran
ARAlireza Rezaee
Alireza Rezaee
RSRoxana Sahebnasagh
Roxana Sahebnasagh
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Degenerative disorders of joints, especially osteoarthritis (OA), result in persistent pain and disability and high costs to society. Nevertheless, the molecular mechanisms of OA have not yet been fully explained. OA is characterized by destruction of cartilage and loss of extracellular matrix (ECM). It is generally agreed that there is an association between pro-inflammatory cytokines and the development of OA. There is increased expression of matrix metalloproteinase (MMP) and “a disintegrin and metalloproteinase with thrombospondin motifs” (ADAMTS). Mesenchymal stem cells (MSCs) have been explored as a new treatment for OA during the last decade. It has been suggested that paracrine secretion of trophic factors, in which exosomes have a crucial role, contributes to the mechanism of MSC-based treatment of OA. The paracrine secretion of exosomes may play a role in the repair of joint tissue as well as MSC-based treatments for other disorders. Exosomes isolated from various stem cells may contribute to tissue regeneration in the heart, limbs, skin, and other tissues. Recent studies have indicated that exosomes (or similar particles) derived from MSCs may suppress OA development. Herein, for first time, we summarize the recent findings of studies on various exosomes derived from MSCs and their effectiveness in the treatment of OA. Moreover, we highlight the likely mechanisms of actions of exosomes in OA.

1 June 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
JNJavid Sadri Nahand
Javid Sadri Nahand
LSLayla Shojaie
Layla Shojaie
SASeyed Amirreza Akhlagh
Seyed Amirreza Akhlagh
MEMohammad Saeid Ebrahimi
Mohammad Saeid Ebrahimi
HMHamid Reza Mirzaei
Hamid Reza Mirzaei
HMHamed Mirzaei
Hamed Mirzaei
Viral infections lead to the death of more than a million people each year around the world, both directly and indirectly. Viruses interfere with many cell functions, particularly critical pathways for cell death, by affecting various intracellular mediators. MicroRNAs (miRNAs) are a major example of these mediators because they are involved in many (if not most) cellular mechanisms. Virus-regulated miRNAs have been implicated in three cell death pathways, namely, apoptosis, autophagy, and anoikis. Several molecules (e.g., BECN1 and B cell lymphoma 2 [BCL2] family members) are involved in both apoptosis and autophagy, while activation of anoikis leads to cell death similar to apoptosis. These mechanistic similarities suggest that common regulators, including some miRNAs (e.g., miR-21 and miR-192), are involved in different cell death pathways. Because the balance between cell proliferation and cell death is pivotal to the homeostasis of the human body, miRNAs that regulate cell death pathways have drawn much attention from researchers. miR-21 is regulated by several viruses and can affect both apoptosis and anoikis via modulating various targets, such as PDCD4, PTEN, interleukin (IL)-12, Maspin, and Fas-L. miR-34 can be downregulated by viral infection and has different effects on apoptosis, depending on the type of virus and/or host cell. The present review summarizes the existing knowledge on virus-regulated miRNAs involved in the modulation of cell death pathways. Understanding the mechanisms for virus-mediated regulation of cell death pathways could provide valuable information to improve the diagnosis and treatment of many viral diseases.

1 November 2020 in Pharmacological Research
Verified
Journal Article
Closed access
MPMohammad Hossein Pourhanifeh
Mohammad Hossein Pourhanifeh
Massoud VosoughMassoud Vosough
Massoud Vosough
MMMaryam Mahjoubin-Tehran
Maryam Mahjoubin-Tehran
MHMaryam Hashemipour
Maryam Hashemipour
MNMajid Nejati
Majid Nejati
HMHamed Mirzaei
Hamed Mirzaei

16 October 2019 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
SMSoheila Mohammadi
Soheila Mohammadi
FYFatemeh Yousefi
Fatemeh Yousefi
ZSZahra Shabaninejad
Zahra Shabaninejad
AMAhmad Movahedpour
Ahmad Movahedpour
MMMaryam Mahjoubin-Tehran
Maryam Mahjoubin-Tehran
HMHamed Mirzaei
Hamed Mirzaei

11 January 2021 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
ADAmirhossein Davoodvandi
Amirhossein Davoodvandi
HMHavva Marzban
Havva Marzban
Pouya GoleijPouya Goleij
Pouya Goleij
ASAmirhossein Sahebkar
Amirhossein Sahebkar
KMKorosh Morshedi
Korosh Morshedi
HMHamed Mirzaei
Hamed Mirzaei
Probiotics are beneficial bacteria that exist within the human gut, and which are also present in different food products and supplements. They have been investigated for some decades, due to their potential beneficial impact on human health. Probiotics compete with pathogenic microorganisms for adhesion sites within the gut, to antagonize them or to regulate the host immune response resulting in preventive and therapeutic effects. Therefore, dysbiosis, defined as an impairment in the gut microbiota, could play a role in various pathological conditions, such as lactose intolerance, gastrointestinal and urogenital infections, various cancers, cystic fibrosis, allergies, inflammatory bowel disease, and can also be caused by antibiotic side effects. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate gene expression in a post-transcriptional manner. miRNAs are biochemical biomarkers that play an important role in almost all cellular signaling pathways in many healthy and disease states. For the first time, the present review summarizes current evidence suggesting that the beneficial properties of probiotics could be explained based on the pivotal role of miRNAs.

11 January 2021 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
RSRana Shafabakhsh
Rana Shafabakhsh
FAFarzaneh Arianfar
Farzaneh Arianfar
Massoud VosoughMassoud Vosough
Massoud Vosough
HMHamid Reza Mirzaei
Hamid Reza Mirzaei
MMMaryam Mahjoubin-Tehran
Maryam Mahjoubin-Tehran
HMHamed Mirzaei
Hamed Mirzaei